LMNL — Liminal BioSciences Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- $27.62m
- $14.21m
- CA$0.40m
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy
Liminal BioSciences jumps on buyout by Thomvest
U.S. STOCKS ON THE MOVE-Domino's Pizza, Amazon, Salesforce
Brief: Liminal Biosciences Announces Arrangement Agreement With Structured Alpha LP
Liminal BioSciences jumps on buyout by Thomvest
Brief: Liminal Biosciences Provides Research And Development Update
Brief: Liminal Biosciences Special Committee Of Board Of Directors Retains Independent Financial Advisor
Brief: Liminal Biosciences Special Committee Of Board Of Directors Retains Independent Financial Advisor
U.S. STOCKS ON THE MOVE-Allete, Gilead Sciences, Arcutis
Liminal BioSciences surges on Thomvest's buyout offer
U.S. STOCKS ON THE MOVE-FedEx, Liminal Biosciences, Kura Sushi
Brief: Liminal Biosciences Confirms Receipt Of Unsolicited Non-Binding Transaction Proposal
Liminal BioSciences surges on Thomvest's buyout offer
Brief: Thomvest Submits Proposal To Acquire Liminal Biosciences On An All Cash Basis
Brief: Liminal Biosciences Reports Q4 And Year Ended 2022 Financial Results
Brief: Liminal Biosciences Regains Compliance With Nasdaq Minimum Bid Price Requirement